Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
966.30
Dollar change
0.00
Percentage change
0.00
%
IndexNDX, S&P 500 P/E27.80 EPS (ttm)34.75 Insider Own4.26% Shs Outstand107.60M Perf Week-0.07%
Market Cap106.06B Forward P/E20.36 EPS next Y47.45 Insider Trans-1.82% Shs Float105.09M Perf Month-2.72%
Income3.95B PEG3.78 EPS next Q10.04 Inst Own84.71% Short Float1.32% Perf Quarter13.75%
Sales13.12B P/S8.09 EPS this Y3.08% Inst Trans-0.34% Short Ratio2.75 Perf Half Y16.08%
Book/sh237.41 P/B4.07 EPS next Y5.12% ROA12.67% Short Interest1.39M Perf Year17.78%
Cash/sh98.80 P/C9.78 EPS next 5Y7.36% ROE16.26% 52W Range684.80 - 998.33 Perf YTD10.02%
Dividend Est.- P/FCF27.37 EPS past 5Y10.31% ROI13.79% 52W High-3.21% Beta0.11
Dividend TTM- Quick Ratio4.94 Sales past 5Y19.99% Gross Margin82.95% 52W Low41.11% ATR (14)15.27
Dividend Ex-Date- Current Ratio5.69 EPS Y/Y TTM-8.55% Oper. Margin32.64% RSI (14)52.58 Volatility1.21% 1.60%
Employees13450 Debt/Eq0.10 Sales Y/Y TTM7.76% Profit Margin30.14% Recom1.86 Target Price1033.50
Option/ShortYes / Yes LT Debt/Eq0.10 EPS Q/Q-2.96% Payout0.00% Rel Volume0.00 Prev Close966.30
Sales Surprise4.25% EPS Surprise10.52% Sales Q/Q0.58% EarningsFeb 02 BMO Avg Volume505.61K Price966.30
SMA20-0.07% SMA500.88% SMA20014.33% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Mar-12-24Initiated Bernstein Outperform $1125
Jan-12-24Upgrade RBC Capital Mkts Sector Perform → Outperform $884 → $1076
Nov-09-23Initiated Deutsche Bank Hold $800
Nov-03-23Upgrade Raymond James Mkt Perform → Outperform $950
Aug-21-23Upgrade Canaccord Genuity Hold → Buy $720 → $992
Aug-21-23Reiterated Oppenheimer Perform $950 → $1050
Jun-28-23Downgrade Canaccord Genuity Buy → Hold $953 → $720
Mar-27-23Upgrade SVB Securities Market Perform → Outperform $834 → $976
Mar-24-23Upgrade Jefferies Hold → Buy $675 → $925
Mar-23-23Upgrade Raymond James Underperform → Mkt Perform
Today 08:00AM
01:00AM
Mar-26-24 10:37AM
Mar-25-24 07:55AM
07:27AM
07:07AM Loading…
07:07AM
07:00AM
Mar-18-24 01:28PM
Mar-17-24 05:20PM
Mar-13-24 10:55AM
Mar-12-24 11:55PM
12:32PM
Mar-11-24 07:00AM
Mar-09-24 05:52AM
Mar-08-24 08:15AM
07:00AM Loading…
07:00AM
Mar-05-24 07:31AM
Mar-04-24 04:09PM
Feb-23-24 10:20AM
01:00AM
01:00AM
Feb-22-24 01:55PM
Feb-21-24 10:00AM
07:00AM
Feb-18-24 12:45AM
Feb-16-24 01:00AM
12:59AM
Feb-10-24 08:30AM
Feb-09-24 06:45AM
Feb-06-24 04:05PM
06:45AM Loading…
06:45AM
Feb-05-24 07:00AM
Feb-03-24 08:10AM
01:53AM
Feb-02-24 03:43PM
02:09PM
12:05PM
11:20AM
09:30AM
07:45AM
07:32AM
07:01AM
06:59AM
06:55AM
06:49AM
06:47AM
06:30AM
06:00AM
Feb-01-24 05:23PM
05:01PM
02:07AM
Jan-31-24 11:20AM
Jan-30-24 09:15AM
07:32AM
07:09AM
07:00AM
04:15AM
Jan-27-24 07:54AM
Jan-26-24 10:00AM
Jan-25-24 11:52PM
02:49PM
02:34PM
02:30PM
02:29PM
Jan-24-24 06:30PM
12:05PM
Jan-21-24 07:15AM
Jan-17-24 11:21AM
04:30AM
Jan-16-24 07:00AM
Jan-12-24 04:04PM
12:00PM
Jan-10-24 10:51AM
10:07AM
Jan-09-24 11:24AM
Jan-08-24 04:40PM
08:04AM
07:30AM
06:51AM
06:48AM
Jan-05-24 04:05PM
Jan-04-24 02:52PM
12:47PM
08:30AM
01:21AM
Jan-03-24 12:20PM
10:32AM
Dec-27-23 04:33PM
Dec-22-23 09:45AM
Dec-21-23 08:15PM
Dec-18-23 04:05PM
Dec-17-23 05:00AM
Dec-16-23 07:01AM
Dec-14-23 09:00AM
Dec-12-23 03:04PM
Dec-11-23 07:30AM
Dec-10-23 07:30PM
12:30PM
Dec-08-23 12:07PM
07:45AM
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MURPHY ANDREW JEVP ResearchMar 14 '24Sale956.475,7835,531,29048,306Mar 15 04:01 PM
MURPHY ANDREW JEVP ResearchMar 13 '24Option Exercise399.6620,0007,993,20068,306Mar 15 04:01 PM
McCourt MarionEVP CommercialMar 01 '24Sale967.50358346,36513,431Mar 05 04:01 PM
RYAN ARTHUR FDirectorMar 01 '24Sale982.0510098,20518,282Mar 05 04:01 PM
SING GEORGE LDirectorFeb 26 '24Option Exercise413.331,000413,33026,849Feb 28 04:04 PM
Bassler Bonnie LDirectorFeb 26 '24Option Exercise391.92854334,7002,236Feb 26 04:07 PM
SING GEORGE LDirectorFeb 26 '24Sale992.501,000992,50026,349Feb 28 04:04 PM
LAROSA JOSEPH JEVP General Counsel and SecretFeb 26 '24Sale990.001,000990,00036,543Feb 28 04:04 PM
Bassler Bonnie LDirectorFeb 26 '24Sale979.25854836,2801,382Feb 26 04:07 PM
SING GEORGE LDirectorFeb 23 '24Option Exercise413.33500206,66526,849Feb 26 04:07 PM
SING GEORGE LDirectorFeb 23 '24Sale985.00500492,50026,349Feb 26 04:07 PM
SING GEORGE LDirectorFeb 22 '24Option Exercise413.333,0001,239,99027,349Feb 26 04:07 PM
SING GEORGE LDirectorFeb 22 '24Sale965.003,0002,895,00026,349Feb 26 04:07 PM
LAROSA JOSEPH JEVP General Counsel and SecretFeb 22 '24Sale967.651,000967,65037,543Feb 26 04:07 PM
YANCOPOULOS GEORGEBd. Co-Chair, President & CSOFeb 15 '24Option Exercise399.66172,72369,030,474925,209Feb 20 04:03 PM
Van Plew Daniel PEVP & General Mgr, IndustrialFeb 14 '24Sale942.2810,4349,831,72720,378Feb 16 04:15 PM
Van Plew Daniel PEVP & General Mgr, IndustrialFeb 09 '24Option Exercise378.3035,37513,382,51047,153Feb 13 04:04 PM
SING GEORGE LDirectorFeb 09 '24Option Exercise413.33500206,66526,849Feb 12 04:02 PM
Fenimore Christopher R.SVP Finance & CFOFeb 09 '24Sale953.314,9194,689,32014,372Feb 12 04:02 PM
SING GEORGE LDirectorFeb 09 '24Sale955.00500477,50026,349Feb 12 04:02 PM
SING GEORGE LDirectorFeb 08 '24Option Exercise413.33500206,66526,849Feb 12 04:02 PM
SING GEORGE LDirectorFeb 08 '24Sale945.00500472,50026,349Feb 12 04:02 PM
STAHL NEILEVP Research and DevelopmentFeb 07 '24Sale950.358,0377,637,95452,019Feb 08 04:02 PM
LAROSA JOSEPH JEVP General Counsel and SecretFeb 07 '24Sale950.001,000950,00038,543Feb 09 04:12 PM
McCourt MarionEVP CommercialFeb 05 '24Sale934.711,000934,71013,789Feb 06 04:08 PM
STAHL NEILEVP Research and DevelopmentFeb 02 '24Option Exercise399.6630,75012,289,54582,769Feb 06 04:08 PM
Landry Robert EEVP Finance CFOFeb 02 '24Option Exercise378.98400151,59223,974Feb 06 04:08 PM
McCourt MarionEVP CommercialFeb 01 '24Sale945.61273258,15214,789Feb 02 04:02 PM
RYAN ARTHUR FDirectorFeb 01 '24Sale954.2210095,42218,382Feb 05 04:05 PM
Landry Robert EEVP Finance CFOJan 31 '24Option Exercise378.98400151,59223,856Feb 02 04:02 PM
Bassler Bonnie LDirectorJan 30 '24Option Exercise380.95827315,0462,209Jan 31 04:52 PM
Bassler Bonnie LDirectorJan 30 '24Sale959.00827793,0931,382Jan 31 04:52 PM
Landry Robert EEVP Finance CFOJan 24 '24Option Exercise378.98500189,49023,808Jan 25 04:17 PM
Fenimore Christopher R.SVP ControllerJan 23 '24Option Exercise477.6710,0004,776,65022,874Jan 25 04:17 PM
GOLDSTEIN JOSEPH LDirectorJan 23 '24Option Exercise625.602,7071,693,4999,089Jan 25 04:18 PM
Landry Robert EEVP Finance CFOJan 23 '24Option Exercise378.981,100416,87824,084Jan 25 04:17 PM
GOLDSTEIN JOSEPH LDirectorJan 23 '24Sale950.002,7072,571,6506,382Jan 25 04:18 PM
Landry Robert EEVP Finance CFOJan 17 '24Option Exercise378.98500189,49023,338Jan 18 04:02 PM
Landry Robert EEVP Finance CFOJan 12 '24Option Exercise378.98800303,18423,406Jan 17 04:03 PM
Landry Robert EEVP Finance CFOJan 04 '24Option Exercise378.98500189,49022,948Jan 08 04:02 PM
LAROSA JOSEPH JEVP General Counsel and SecretJan 03 '24Option Exercise399.6634,00013,588,44064,036Jan 04 04:19 PM
Fenimore Christopher R.SVP ControllerJan 03 '24Option Exercise477.6710,0004,776,65020,329Jan 04 04:22 PM
Landry Robert EEVP Finance CFOJan 03 '24Option Exercise378.981,100416,87823,136Jan 04 04:19 PM
Bassler Bonnie LDirectorJan 03 '24Option Exercise380.95826314,6652,208Jan 04 04:11 PM
Bassler Bonnie LDirectorJan 03 '24Sale914.00826754,9641,382Jan 04 04:11 PM
Zoghbi Huda YDirectorJan 02 '24Option Exercise391.921,117437,7752,364Jan 04 04:11 PM
Landry Robert EEVP Finance CFOJan 02 '24Option Exercise378.98650246,33722,457Jan 04 04:19 PM
YANCOPOULOS GEORGEBd. Co-Chair, President & CSOJan 02 '24Sale900.0016,84815,163,200180,000Jan 04 04:20 PM
Zoghbi Huda YDirectorJan 02 '24Sale900.001,1171,005,3001,247Jan 04 04:11 PM
McCourt MarionEVP CommercialJan 02 '24Sale873.91274239,45115,062Jan 04 04:17 PM
RYAN ARTHUR FDirectorJan 02 '24Sale899.9010089,99018,347Jan 04 04:08 PM
Landry Robert EEVP Finance CFODec 28 '23Option Exercise378.98850322,13322,419Dec 29 04:05 PM
BROWN MICHAEL SDirectorDec 27 '23Option Exercise482.682,049989,0113,296Dec 29 04:06 PM
Landry Robert EEVP Finance CFODec 27 '23Option Exercise378.98750284,23522,111Dec 29 04:05 PM
Fenimore Christopher R.SVP ControllerDec 27 '23Sale856.712,4482,097,22614,372Dec 29 04:04 PM
BROWN MICHAEL SDirectorDec 27 '23Sale898.002,0491,840,0021,247Dec 29 04:06 PM
Fenimore Christopher R.SVP ControllerDec 22 '23Sale846.27250211,56816,820Dec 26 04:08 PM
Fenimore Christopher R.SVP ControllerDec 21 '23Sale844.011,6801,417,93417,070Dec 26 04:08 PM
Landry Robert EEVP Finance CFODec 13 '23Option Exercise378.981,000378,98022,084Dec 14 04:08 PM
Bassler Bonnie LDirectorDec 13 '23Option Exercise376.69610229,7811,857Dec 14 04:07 PM
Bassler Bonnie LDirectorDec 13 '23Sale870.00610530,7001,247Dec 14 04:07 PM
McCourt MarionEVP CommercialDec 11 '23Sale838.44270226,37920,814Dec 12 04:04 PM
MURPHY ANDREW JEVP ResearchDec 05 '23Sale817.446,5365,342,78759,421Dec 06 04:02 PM
MURPHY ANDREW JEVP ResearchDec 04 '23Option Exercise270.4320,0005,408,60079,421Dec 06 04:02 PM
RYAN ARTHUR FDirectorDec 01 '23Sale817.3010081,73018,447Dec 04 04:02 PM
MURPHY ANDREW JEVP ResearchNov 14 '23Sale799.176,4925,188,21359,421Nov 15 04:02 PM
MURPHY ANDREW JEVP ResearchNov 13 '23Option Exercise270.4320,0005,408,60079,421Nov 15 04:02 PM
RYAN ARTHUR FDirectorNov 07 '23Sale827.9010082,79018,547Nov 08 04:07 PM
McCourt MarionEVP CommercialNov 01 '23Option Exercise381.401,000381,40020,803Nov 02 04:03 PM
McCourt MarionEVP CommercialNov 01 '23Sale783.911,000783,91019,803Nov 02 04:03 PM
Zoghbi Huda YDirectorOct 13 '23Option Exercise391.921,000391,9202,247Oct 17 04:06 PM
Zoghbi Huda YDirectorOct 13 '23Sale850.001,000850,0001,247Oct 17 04:06 PM
McCourt MarionEVP CommercialOct 02 '23Option Exercise372.461,038386,61320,841Oct 03 04:04 PM
McCourt MarionEVP CommercialOct 02 '23Sale827.001,038858,42619,803Oct 03 04:04 PM
McCourt MarionEVP CommercialSep 01 '23Sale834.55250208,63819,803Sep 06 04:03 PM
Van Plew Daniel PEVP & General Mgr, IndustrialAug 24 '23Sale841.716,1975,216,07321,508Aug 25 04:02 PM
Van Plew Daniel PEVP & General Mgr, IndustrialAug 23 '23Option Exercise381.4023,1258,819,87544,633Aug 25 04:02 PM
POON CHRISTINE ADirectorAug 23 '23Option Exercise273.6712,2803,360,66814,317Aug 25 04:02 PM
Fenimore Christopher R.SVP ControllerAug 23 '23Option Exercise399.667,0002,797,62026,140Aug 25 04:03 PM
POON CHRISTINE ADirectorAug 23 '23Sale839.9712,28010,314,8292,037Aug 25 04:02 PM
Landry Robert EEVP Finance CFOAug 23 '23Sale844.00223188,21231,699Aug 25 04:02 PM
STAHL NEILEVP Research and DevelopmentAug 22 '23Sale840.9811,6659,810,08253,100Aug 23 04:03 PM
STAHL NEILEVP Research and DevelopmentAug 21 '23Option Exercise399.6650,00019,983,000103,100Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 21 '23Option Exercise391.92853334,3082,100Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 21 '23Sale829.00853707,1371,247Aug 23 04:03 PM
Bassler Bonnie LDirectorAug 10 '23Option Exercise391.92853334,3082,100Aug 11 04:13 PM
Bassler Bonnie LDirectorAug 10 '23Sale789.00853673,0171,247Aug 11 04:13 PM
McCourt MarionEVP CommercialAug 01 '23Sale744.66250186,16520,053Aug 03 04:02 PM
RYAN ARTHUR FDirectorAug 01 '23Sale736.5910073,65918,647Aug 03 04:25 PM
McCourt MarionEVP CommercialJul 03 '23Sale710.09250177,52220,303Jul 06 04:02 PM
RYAN ARTHUR FDirectorJul 03 '23Sale716.8810071,68818,747Jul 06 04:01 PM
McCourt MarionEVP CommercialJun 01 '23Sale736.00250184,00020,553Jun 02 04:12 PM
RYAN ARTHUR FDirectorJun 01 '23Sale735.4210073,54218,847Jun 02 04:14 PM
RYAN ARTHUR FDirectorMay 01 '23Sale805.3310080,53318,947May 03 04:01 PM
BROWN MICHAEL SDirectorApr 21 '23Option Exercise520.013,0701,596,4314,317Apr 24 04:05 PM
BROWN MICHAEL SDirectorApr 21 '23Sale798.423,0702,451,1491,247Apr 24 04:05 PM
McCourt MarionEVP CommercialApr 03 '23Option Exercise372.461,100409,70621,903Apr 05 04:00 PM
McCourt MarionEVP CommercialApr 03 '23Sale818.801,100900,68020,803Apr 05 04:00 PM
RYAN ARTHUR FDirectorApr 03 '23Sale819.3110081,93119,047Apr 05 04:01 PM